Director/PDMR Shareholding
Updated : 12:00
Anglo American plc ("the Company")
Registered office: 20 Carlton House Terrace, London SW1Y 5AN
Registered number: 3564138 (incorporated in England and Wales)
LEI: 549300S9XF92D1X8ME43
Notification of transactions by PDMR
The Company received notification on 5 August 2019 of the purchase of 2,000 of the Company's American Depositary Shares (ADS) by a Non-Executive Director, equivalent to 1,000 Ordinary Shares. One ADS represents 0.5 Ordinary Shares.
In accordance with Article 19 of the EU Market Abuse Regulation, the relevant FCA notifications are set out below.
1. | Details of PDMR / person closely associated (PCA) | |||||
a) | Name | Byron Grote | ||||
2. | Reason for the notification | |||||
a) | Position / status | Senior Independent Non-Executive Director (PDMR) | ||||
b) | Initial notification / amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Full name of the entity | Anglo American plc | ||||
b) | LEI | 549300S9XF92D1X8ME43 | ||||
4.1 | Details of the transaction(s) | |||||
a) | Description of the financial instrument
Identification Code | Anglo American plc American Depositary Shares (ADS), each ADS represented by 0.5 Ordinary Shares of USD0.54945 each
US03485P3001 | ||||
b) | Nature of the transaction | Purchase of 2,000 American Depositary Shares, equivalent to 1,000 Ordinary Shares | ||||
c) | Currency | USD - United States Dollar | ||||
d) | Price(s) and volume(s) |
| ||||
e) | Aggregated information
Aggregated volume
Price |
2,000
USD11.07 | ||||
f) | Date of the transaction | 2019-08-05 | ||||
g) | Place of the transaction | New York Stock Exchange - XNYS |
Ellie Klonarides
Deputy Company Secretary
6 August 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.